James A. Williams

1.5k total citations
34 papers, 985 citations indexed

About

James A. Williams is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Surgery. According to data from OpenAlex, James A. Williams has authored 34 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in James A. Williams's work include Renal cell carcinoma treatment (8 papers), Cancer Genomics and Diagnostics (7 papers) and Renal and related cancers (6 papers). James A. Williams is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Cancer Genomics and Diagnostics (7 papers) and Renal and related cancers (6 papers). James A. Williams collaborates with scholars based in United States, Italy and Canada. James A. Williams's co-authors include Donald Regula, R Hale, C. H. Buckley, H. Fox, Laurence A. Boxer, Robert J. Motzer, Thomas N. Salthouse, William J. Gullick, Xin Huang and Patricia A. English and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

James A. Williams

33 papers receiving 928 citations

Peers

James A. Williams

PRM

ONCOL

SURGE

HEMAT

Gabriella Bernini Italy

Şevket Ruacan Türkiye

Dong Zheng China

Janina Kamińska Poland

S. Niemi Finland

Mark Weinberg United States

Daniel Helbling Switzerland

Richard W. Nicholas United States

K. P. H. Pritzker Canada

Ramazan Yıldız Türkiye

Gabriella Bernini Italy

James A. Williams

530 ×1.6

PRM

336 ×1.2

ONCOL

278 ×1.1

SURGE

304 ×1.3

90 ×0.7

HEMAT

Citations per year, relative to James A. Williams James A. Williams (= 1×) peers Gabriella Bernini

Countries citing papers authored by James A. Williams

Since Specialization

Citations

This map shows the geographic impact of James A. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Williams more than expected).

Fields of papers citing papers by James A. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Williams. The network helps show where James A. Williams may publish in the future.

Co-authorship network of co-authors of James A. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Williams. A scholar is included among the top collaborators of James A. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Williams. James A. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schafernak, Kristian T., et al.. (2021). Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma. Cancer Genetics. 258-259. 23–26. 5 indexed citations

Motzer, Robert J., Robert A. Figlin, Jean-François Martini, et al.. (2017). Germline Genetic Biomarkers of Sunitinib Efficacy in Advanced Renal Cell Carcinoma: Results From the RENAL EFFECT Trial. Clinical Genitourinary Cancer. 15(5). 526–533. 8 indexed citations

Chellapandian, Deepak, Rui Zhang, Michael Jeng, et al.. (2016). Hemophagocytic Lymphohistiocytosis (HLH) in Langerhans Cell Histiocytosis (LCH): A Multicenter Retrospective Descriptional Study. Blood. 128(22). 707–707. 2 indexed citations

Escudier, Bernard, Brian I. Rini, Robert J. Motzer, et al.. (2015). Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 13(4). 328–337.e3. 29 indexed citations

Motzer, Robert J., Thomas E. Hutson, Gary R. Hudes, et al.. (2014). Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma. Cancer Chemotherapy and Pharmacology. 74(4). 739–750. 56 indexed citations

Barnabé, Cheryl, Sebastian Kraus, Hubert Marotte, et al.. (2014). FRI0249 Case Definition for Erosions Imaged with High Resolution Peripheral Quantitative Computed Tomography (HR-PQCT): an International Spectra Reliability Exercise-1 (RELEX-1). Annals of the Rheumatic Diseases. 73. 473–474. 2 indexed citations

Harmon, Charles S., Samuel E. DePrimo, Robert A. Figlin, et al.. (2013). Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma. Cancer Chemotherapy and Pharmacology. 73(1). 151–161. 47 indexed citations

Cutsem, Eric Van, Feng Gao, James A. Williams, et al.. (2011). ASSOCIATIONS BETWEEN GERMLINE GENOTYPE AND EFFICACY AND SAFETY OUTCOMES IN A PHASE III STUDY OF SUNITINIB AND FOLFIRI IN METASTATIC COLORECTAL CANCER (MCRC). Annals of Oncology. 22. 1 indexed citations

Escudier, Bernard, A. Katrina Loomis, А. Д. Каприн, et al.. (2011). 7103 ORAL Association of Single Nucleotide Polymorphisms (SNPs) in VEGF Pathway Genes With Progression-free Survival (PFS) and Blood Pressure (BP) in Metastatic Renal Cell Carcinoma (mRCC) in the Phase 3 Trial of Axitinib Versus Sorafenib (AXIS Trial). European Journal of Cancer. 47. S505–S505. 21 indexed citations

10.

Onyekwere, Onyinye, Andrew Campbell, Gregory J. Ensing, et al.. (2007). Pulmonary Hypertension in Children and Adolescents with Sickle Cell Disease. Pediatric Cardiology. 29(2). 309–312. 70 indexed citations

11.

Armstrong, Michael B., Olubukola O. Nafiu, Riccardo Valdez, et al.. (2005). Testicular Chloroma in a Nonleukemic Infant. Journal of Pediatric Hematology/Oncology. 27(7). 393–396. 9 indexed citations

12.

Schwartz, Jennifer, et al.. (2004). High‐risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatric Blood & Cancer. 44(5). 441–448. 32 indexed citations

13.

Hale, R, et al.. (1993). Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.. Journal of Clinical Pathology. 46(2). 149–153. 78 indexed citations

14.

Hale, R, C. H. Buckley, H. Fox, & James A. Williams. (1992). Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.. Journal of Clinical Pathology. 45(7). 594–596. 52 indexed citations

15.

Williams, James A. & Eugene J.‐M.A. Thonar. (1989). Early osteophyte formation after chemically induced articular cartilage injury. The American Journal of Sports Medicine. 17(1). 7–15. 17 indexed citations

16.

Daniel, Rollin K., Disa Lidman, Michael Olding, James A. Williams, & Barbara F. Matlaga. (1984). An Anastomotic Device for Microvascular Surgery: Evolution. Annals of Plastic Surgery. 13(5). 402–411. 17 indexed citations

17.

Williams, James A., et al.. (1975). The management of postoperative ureterovaginal fistulae.. PubMed. 67(1). 69–70. 1 indexed citations

18.

Solliday, Norman H., et al.. (1973). Familial chronic interstitial pneumonia.. PubMed. 108(2). 193–204. 34 indexed citations

19.

Williams, James A., et al.. (1969). Neurological Disease after Partial Gastrectomy. BMJ. 3(5664). 210–212. 21 indexed citations

20.

Salthouse, Thomas N. & James A. Williams. (1969). Histochemical observations of enzyme activity at suture implant sites. Journal of Surgical Research. 9(8). 481–486. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact